131 related articles for article (PubMed ID: 22025639)
1. Funding mechanisms and program management at the National Heart, Lung, and Blood Institute: confronting new challenges and exploring new opportunities.
Shurin SB
Circulation; 2011 Oct; 124(17):1894-6. PubMed ID: 22025639
[No Abstract] [Full Text] [Related]
2. Funding mechanisms and program management at the National Heart, Lung, and Blood Institute: confronting new challenges and exploring new opportunities.
Shurin SB
Blood; 2011 Nov; 118(20):5380-2. PubMed ID: 21868577
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis Research: Extramural Portfolio Supported by the National Heart, Lung, and Blood Institute, 2008-2015.
Gao Y; Stanley DV; Robinson VC; Reid DM; Galis ZS
Circ Res; 2017 May; 120(11):1713-1717. PubMed ID: 28546354
[No Abstract] [Full Text] [Related]
4. How one program at the National Heart, Lung, and Blood Institute establishes its scientific priorities.
Bild DE; Lauer MS
J Am Coll Cardiol; 2009 Jun; 53(24):2259-61. PubMed ID: 19520248
[No Abstract] [Full Text] [Related]
5. The NHLBI SMARTT Program: A Novel Approach to Facilitate Translational Research for Heart, Lung and Blood Diseases.
Ebert RF; Danthi NS; Charette MF; Hanspal M; Mondoro TH; Noel PJ; Olive M; Punturieri A; Moore TM
Circ Res; 2016 Jun; 118(12):1867-71. PubMed ID: 27283530
[TBL] [Abstract][Full Text] [Related]
6. An update from the United States National Heart, Lung, and Blood Institute-funded Production Assistance for Cellular Therapies (PACT) program: a decade of cell therapy.
Wood D; Wesselschmidt R; Hematti P; Gee AP; Rooney C; Silberstein L; Armant M; Couture L; Wagner JE; McKenna DH; Hei D; Mondoro TH; Welniak L; Lindblad R
Clin Transl Sci; 2014 Apr; 7(2):93-9. PubMed ID: 24655892
[No Abstract] [Full Text] [Related]
7. Portfolio analysis on preeclampsia and pregnancy-associated hypertension research funded by the National Heart, Lung, and Blood Institute.
Maric-Bilkan C
Physiol Genomics; 2018 Nov; 50(11):982-987. PubMed ID: 30265594
[TBL] [Abstract][Full Text] [Related]
8. Notes from the Director, National Heart, Lung, and Blood Institute: transitions.
Nabel EG
Blood; 2009 Mar; 113(13):2875-7. PubMed ID: 19324910
[TBL] [Abstract][Full Text] [Related]
9. The vascular surgeon-scientist: a 15-year report of the Society for Vascular Surgery Foundation/National Heart, Lung, and Blood Institute-mentored Career Development Award Program.
Kibbe MR; Dardik A; Velazquez OC; Conte MS;
J Vasc Surg; 2015 Apr; 61(4):1050-7. PubMed ID: 25814368
[TBL] [Abstract][Full Text] [Related]
10. National Heart, Lung, and Blood Institute and the American Recovery and Reinvestment Act of 2009: 1 year later.
Lauer MS
J Am Coll Cardiol; 2010 Jul; 56(3):234-6. PubMed ID: 20620744
[No Abstract] [Full Text] [Related]
11. Nanotechnology research support at the National Heart, Lung, and Blood Institute.
Buxton DB
Circ Res; 2011 Jul; 109(3):250-4. PubMed ID: 21778434
[No Abstract] [Full Text] [Related]
12. Predicting Productivity Returns on Investment: Thirty Years of Peer Review, Grant Funding, and Publication of Highly Cited Papers at the National Heart, Lung, and Blood Institute.
Lauer MS; Danthi NS; Kaltman J; Wu C
Circ Res; 2015 Jul; 117(3):239-43. PubMed ID: 26089369
[TBL] [Abstract][Full Text] [Related]
13. "The Good Old R01": Challenging Downward Funding Success Trends at the National Heart, Lung, and Blood Institute.
Oh YS; Robinson V; Stanley DV; Tolunay E; Kim DY; Galis ZS
Circ Res; 2016 May; 118(10):1475-9. PubMed ID: 27174948
[TBL] [Abstract][Full Text] [Related]
14. Studies comparing treatment options receive a boost.
Nair P
Nat Med; 2009 May; 15(5):468. PubMed ID: 19424190
[No Abstract] [Full Text] [Related]
15. Support for cardiovascular cell therapy research at the National Heart, Lung, and Blood Institute.
Buxton DB; Skarlatos SI
Circ Res; 2012 Jun; 110(12):1549-55. PubMed ID: 22679137
[No Abstract] [Full Text] [Related]
16. Cardiovascular tissue engineering research support at the National Heart, Lung, and Blood Institute.
Lundberg MS
Circ Res; 2013 Apr; 112(8):1097-103. PubMed ID: 23580772
[TBL] [Abstract][Full Text] [Related]
17. $1 billion to the National Heart, Lung, and Blood Institute: economic stimulus or bust?
Galani RJ
J Am Coll Cardiol; 2011 Feb; 57(7):889; author reply 889. PubMed ID: 21310329
[No Abstract] [Full Text] [Related]
18. National Heart, Lung, and Blood Institute: transitions.
Nabel EG
Circulation; 2009 Mar; 119(10):1453-5. PubMed ID: 19289650
[No Abstract] [Full Text] [Related]
19. Your tax dollars at work! or the APPLES trial bears fruit.
Phillips B
J Clin Sleep Med; 2008 Oct; 4(5):419-20. PubMed ID: 18853697
[No Abstract] [Full Text] [Related]
20. Citation impact of NHLBI R01 grants funded through the American Recovery and Reinvestment Act as compared to R01 grants funded through a standard payline.
Danthi NS; Wu CO; DiMichele DM; Hoots WK; Lauer MS
Circ Res; 2015 Feb; 116(5):784-8. PubMed ID: 25722441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
